Primary upper-extremity deep vein thrombosis:: High prevalence of thrombophilic defects

被引:56
作者
Hendler, MF [1 ]
Meschengieser, SS [1 ]
Blanco, AN [1 ]
Alberto, MF [1 ]
Salviú, MJ [1 ]
Gennari, L [1 ]
Lazzari, MA [1 ]
机构
[1] Natl Acad Med Buenos Aires, Dept Hemostasia & Trombosis, Inst Invest Hematol Mariano R Castex, RA-1425 Buenos Aires, DF, Argentina
关键词
thrombophilia; Paget-Schroetter syndrome; deep venous thrombosis; upper extremity;
D O I
10.1002/ajh.20131
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Primary deep venous thrombosis of the upper extremity (UEDVT) is an unusual disorder. Limited data are available on the contribution of hypercoagulable status in the pathogenesis of this disease. This study aims to report the prevalence of inherited and acquired thrombophilic risk factors (TF) in patients with primary (effort-related and spontaneous) UEDVT. From 1993 to 2002, 31 patients (17 females, median age 38.8 years, range 16-60 years; and 14 males, median age 31.4 years, range 20-56 years) with primary UEDVT (n = 15 effort-related and n = 16 spontaneous) were referred for screening of hypercoagulable status. Nineteen (61.3%) patients had at least one coagulation abnormality. The most common acquired TF were antiphospholipid antibodies (31% lupus anticoagulant and 12.9% anticardiolipin antibodies). Factor V Leiden (12.9%) and prothrombin G20210A mutation (20%) were the most prevalent genetic risk factors. Five patients (16.1%) had high plasma homocysteine levels, and one patient (4.7%) had protein S deficiency. Effort-related UEDVT was associated with male gender (P = 0.04) and younger age (P = 0.02). There was no significant difference in the prevalence of acquired or inherited TF between patients with effort-related or spontaneous UEDVT. A local anatomic abnormality was detected in seven patients (22.5%), and the prevalence of TF was significantly lower within this group (P = 0.006). The incidence of TF in patients without an anatomic abnormality was 75% (RR 5.25). This study found a high prevalence of an underlying thrombophilic status in spontaneous and effort-related UEDVT. Hypercoagulable status may play a significant role in both groups. Screening for local anatomical abnormalities and thrombophilia should be included in the evaluation of primary UEDVT. (C) 2004 Wiley-Liss, Inc.
引用
收藏
页码:330 / 337
页数:8
相关论文
共 29 条
[1]   MUTATION IN BLOOD-COAGULATION FACTOR-V ASSOCIATED WITH RESISTANCE TO ACTIVATED PROTEIN-C [J].
BERTINA, RM ;
KOELEMAN, BPC ;
KOSTER, T ;
ROSENDAAL, FR ;
DIRVEN, RJ ;
DERONDE, H ;
VANDERVELDEN, PA ;
REITSMA, PH .
NATURE, 1994, 369 (6475) :64-67
[2]   BEHAVIOR OF DILUTED ACTIVATED PARTIAL THROMBOPLASTIN TIME IN PREGNANT-WOMEN WITH A LUPUS ANTICOAGULANT [J].
BLANCO, AN ;
GRAND, BE ;
PIERONI, G ;
PENALVA, LB ;
VOTO, LS ;
LAZZARI, MA .
AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 1993, 100 (02) :99-102
[3]   THROMBOSIS AS A COMPLICATION OF PULMONARY-ARTERY CATHETERIZATION VIA THE INTERNAL JUGULAR VEIN - PROSPECTIVE EVALUATION BY PHLEBOGRAPHY [J].
CHASTRE, J ;
CORNUD, F ;
BOUCHAMA, A ;
VIAU, F ;
BENACERRAF, R ;
GIBERT, C .
NEW ENGLAND JOURNAL OF MEDICINE, 1982, 306 (05) :278-281
[4]   Careful selection of sample dilution and factor-V-deficient plasma makes the modified activated protein C resistance test highly specific for the factor V Leiden mutation [J].
de Ronde, H ;
Bertina, RM .
BLOOD COAGULATION & FIBRINOLYSIS, 1999, 10 (01) :7-17
[5]   Inherited thrombophilia: Pathogenesis, clinical syndromes, and management [J].
DeStefano, V ;
Finazzi, G ;
Mannucci, PM .
BLOOD, 1996, 87 (09) :3531-3544
[6]   Risk factors and management of patients with upper limb deep vein thrombosis [J].
Ellis, MH ;
Manor, Y ;
Witz, M .
CHEST, 2000, 117 (01) :43-46
[7]  
Engel H, 1996, THROMB HAEMOSTASIS, V75, P267
[8]  
FISKERSTRAND T, 1993, CLIN CHEM, V39, P263
[9]   A CANDIDATE GENETIC RISK FACTOR FOR VASCULAR-DISEASE - A COMMON MUTATION IN METHYLENETETRAHYDROFOLATE REDUCTASE [J].
FROSST, P ;
BLOM, HJ ;
MILOS, R ;
GOYETTE, P ;
SHEPPARD, CA ;
MATTHEWS, RG ;
BOERS, GJH ;
DENHEIJER, M ;
KLUIJTMANS, LAJ ;
VANDENHEUVEL, LP ;
ROZEN, R .
NATURE GENETICS, 1995, 10 (01) :111-113
[10]   Prevalence of three prothrombotic polymorphisms:: Factor V G1691A, factor II G20210A and methylenetetrahydrofolate reductase (MTHFR) C 677T in Argentina [J].
Genoud, V ;
Castañon, M ;
Annichino-Bizzacchi, J ;
Korin, J ;
Kordich, L .
THROMBOSIS RESEARCH, 2000, 100 (03) :127-131